JP2023546725A5 - - Google Patents
Info
- Publication number
- JP2023546725A5 JP2023546725A5 JP2023525078A JP2023525078A JP2023546725A5 JP 2023546725 A5 JP2023546725 A5 JP 2023546725A5 JP 2023525078 A JP2023525078 A JP 2023525078A JP 2023525078 A JP2023525078 A JP 2023525078A JP 2023546725 A5 JP2023546725 A5 JP 2023546725A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- amino acid
- domain
- cells
- chimeric protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105744P | 2020-10-26 | 2020-10-26 | |
| US63/105,744 | 2020-10-26 | ||
| PCT/US2021/027294 WO2022093310A1 (en) | 2020-10-26 | 2021-04-14 | Homodimeric and heterodimeric proteins comprising butyrophilin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546725A JP2023546725A (ja) | 2023-11-07 |
| JP2023546725A5 true JP2023546725A5 (cg-RX-API-DMAC7.html) | 2024-04-24 |
Family
ID=81384237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525078A Pending JP2023546725A (ja) | 2020-10-26 | 2021-04-14 | ブチロフィリンを含むホモ二量体及びヘテロ二量体タンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230416333A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4232065A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023546725A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116801897A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021370788A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3196533A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022093310A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024511992A (ja) * | 2021-03-16 | 2024-03-18 | シャタック ラボ,インコーポレイテッド | ガンマデルタt細胞刺激 |
| WO2023102617A1 (en) * | 2021-12-09 | 2023-06-15 | The University Of Melbourne | Modified butyrophilin and butyrophilin complexes |
| WO2024006889A2 (en) * | 2022-06-29 | 2024-01-04 | Shattuck Labs, Inc. | Cd20-targeted gamma delta t cell modulation |
| WO2024006907A2 (en) * | 2022-06-29 | 2024-01-04 | Shattuck Labs, Inc. | B7h3-targeted gamma delta t cell modulation |
| CN118388647A (zh) * | 2022-06-30 | 2024-07-26 | 深圳市乐土生物医药有限公司 | 一种分离的Claudin18.2抗体及其应用 |
| WO2024123812A1 (en) | 2022-12-05 | 2024-06-13 | Shattuck Labs, Inc. | Fusion proteins for the treatment of cardiometabolic diseases |
| CN121752279A (zh) * | 2023-06-30 | 2026-03-27 | 科瑞特医药公司 | 工程化嵌合融合蛋白组合物及其使用方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201913573UA (en) * | 2015-10-01 | 2020-03-30 | Heat Biologics Inc | Compositions and methods for adjoining type i and type ii extracellular domains as heterologous chimeric proteins |
| WO2020047329A1 (en) * | 2018-08-29 | 2020-03-05 | Shattuck Labs, Inc. | Chimeric proteins comprising extracellular domains and uses thereof |
| BR112021013193A2 (pt) * | 2019-01-07 | 2021-09-28 | Shattuck Labs, Inc. | Proteínas heterodiméricas para modulação de células t gama delta |
-
2021
- 2021-04-14 WO PCT/US2021/027294 patent/WO2022093310A1/en not_active Ceased
- 2021-04-14 CA CA3196533A patent/CA3196533A1/en active Pending
- 2021-04-14 AU AU2021370788A patent/AU2021370788A1/en not_active Abandoned
- 2021-04-14 US US18/033,403 patent/US20230416333A1/en not_active Abandoned
- 2021-04-14 EP EP21887084.8A patent/EP4232065A4/en not_active Withdrawn
- 2021-04-14 CN CN202180087304.4A patent/CN116801897A/zh active Pending
- 2021-04-14 JP JP2023525078A patent/JP2023546725A/ja active Pending